ROYAL BANK OF CANADA - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AD2. A total of 47 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,557,000
+29.9%
3,643,000
+25.5%
0.00%0.0%
Q2 2023$2,738,000
-10.7%
2,903,000
-14.1%
0.00%0.0%
Q1 2023$3,066,000
-41.3%
3,378,000
-40.2%
0.00%0.0%
Q4 2022$5,219,000
+17.8%
5,653,000
+26.1%
0.00%0.0%
Q3 2022$4,430,0004,483,0000.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 54,800,000$53,728,9343.15%
CSS LLC/IL 27,690,000$27,111,9721.78%
BRAIDWELL LP 52,740,000$51,764,3101.64%
Sonora Investment Management Group, LLC 12,648,000$12,375,1971.06%
CAMDEN ASSET MANAGEMENT L P /CA 24,900,000$24,314,8500.90%
DeepCurrents Investment Group LLC 20,000,000$19,514,0730.85%
Magnetar Financial LLC 28,500,000$27,924,1660.71%
TENOR CAPITAL MANAGEMENT Co., L.P. 32,000,000$31,366,1230.67%
MACKAY SHIELDS LLC 23,902,000$24,063,6470.66%
SHENKMAN CAPITAL MANAGEMENT INC 8,210,000$8,155,8490.61%
View complete list of IONIS PHARMACEUTICALS INC shareholders